Type 2 Diabetes and Hepatocellular Carcinoma: Risk Factors and Pathogenesis

Keyphrases

• Risk Factors 100%
• Hepatocellular Carcinoma 100%
• Type 2 Diabetes Mellitus (T2DM) 100%
• Hepatocellular Carcinoma Risk 100%
• Low Risk 20%
• Increased Incidence 20%
• Immunomodulation 20%
• Oxidative Stress 20%
• Insulin-like Growth factor-1 20%
• Epidemiological Evidence 20%
• Metabolic Syndrome 20%
• Inflammatory Mediators 20%
• Novel Treatments 20%
• Insulin 20%
• Pathophysiological Mechanisms 20%
• Sulfonylurea 20%
• Metformin 20%
• Gut Microbiota 20%
• JNK1 20%
• Diabetes Obesity 20%

Medicine and Dentistry

• Hepatocellular Carcinoma 100%
• Maturity Onset Diabetes of the Young 100%
• Pathogenesis 100%
• Pathophysiology 33%
• Oxidative Stress 16%
• Metabolic Syndrome 16%
• Mediator 16%
• Glycon 16%
• Insulin 16%
• Immunomodulation 16%
• Gut Microbiota 16%
• Sulfonylurea 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Liver Cell Carcinoma 100%
• Maturity Onset Diabetes of the Young 100%
• Pathogenesis 100%
• Pathophysiology 33%
• Immunomodulation 16%
• Metabolic Syndrome X 16%
• Sulfonylurea 16%
• Metformin 16%
• Insulin 16%
• Intestine Flora 16%